Engflag

Cetriz

Quick links to important sections

Cetriz

Cetriz_SV

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cetriz

What is Cetriz? Defining the Second-Generation Antihistamine

Property Description
Active ingredient Cetirizine Dihydrochloride
Form Oral tablet, oral solution, and syrup
Pharmacological class Second-generation Antihistamine
General purpose Provides general relief from allergic reactions
Origin Synthetic, active metabolite of hydroxyzine

Defining Cetriz: What Type of Medicine is Cetirizine Dihydrochloride?

The medicine Cetriz is a trade name for a product whose active ingredient is Cetirizine Dihydrochloride, which is classified as a potent second-generation antihistamine. This substance is a piperazine derivative, a synthetic organic molecule that emerged as a targeted, active metabolite of the older drug hydroxyzine. The distinction as a "second-generation" agent is widely clinically recognized for its design to be peripherally selective, primarily targeting H1 receptors outside the central nervous system. This molecular refinement results in a selectivity that generally translates into a profile with minimal sedative effects compared to older antihistamines.

Composition, Forms, and General Purpose

The preparation known as Cetriz is primarily a single-ingredient product, consisting solely of Cetirizine Dihydrochloride alongside necessary pharmaceutical excipients. The compound is readily available for oral administration in several dosage forms, including traditional oral tablets, as well as liquid formulations like an oral solution and syrup. The availability of the oral solution form, specifically, allows for easier administration to patient groups requiring liquid preparations.

The general purpose of this medicine is to provide relief from the symptoms resulting from the body's allergic response. It achieves this by acting as a highly selective Histamine H1-receptor antagonist. The medicine works by physically blocking the effects of histamine, the primary chemical released by the immune system that initiates allergic discomfort. The therapeutic aim is to offer general relief from the immediate physiological consequences of an allergic reaction, such as those experienced during a seasonal allergy flare-up.

What side effects are possible with Cetriz?

Possible Side Effects and Safety Information

The safety profile for cetirizine ( Cetriz) is based on data from official regulatory sources, including clinical trials and post-marketing surveillance by government health agencies. This information identifies the known adverse reactions and necessary safety precautions.

Frequency-Classified Adverse Reactions

The most common adverse reactions reported include drowsiness (somnolence), fatigue, dry mouth, headache, and gastrointestinal symptoms such as diarrhea or vomiting. These effects are typically mild.

Less common, rare, or very rare reactions documented in post-marketing reports include serious events such as anaphylaxis (severe allergic reaction), hepatitis or cholestasis (liver problems), convulsions, thrombocytopenia (low platelet count), and glomerulonephritis (kidney inflammation).

Population and Exposure Safety Notes

Safety Consideration Detail
Renal/Hepatic Impairment Dose reduction is required for patients with reduced kidney or liver function to prevent the medicine from accumulating and causing adverse effects.
Performance Impairment Due to the risk of drowsiness, caution is advised when performing tasks requiring full mental alertness, such as driving or operating machinery.
Discontinuation Warning Rare cases of severe pruritus (intense itching) have been reported upon stopping the medicine, particularly after long-term use.

The overall regulatory safety structure emphasizes managing the risk of drowsiness, while acknowledging the need for vigilance regarding dose adjustments in specific patient groups and monitoring for rare, but serious, systemic adverse events.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the manifestations and required emergency actions in the event of an overdose of Cetriz (Cetirizine).

Documented manifestations primarily affect the Central Nervous System (CNS), often presenting as somnolence, sedation, drowsiness, and fatigue. Paradoxical effects, such as restlessness and irritability, are also reported, particularly in children. Other signs observed in overdose cases include tachycardia (fast heart rate), tremor, urinary retention, and mydriasis (dilated pupils).

Required Emergency Actions

Severity ranges up to life-threatening outcomes such as stupor, seizures, and coma. Official guidance mandates that medical help be sought immediately if an overdose is suspected. Users are required to call emergency services immediately if the affected person collapses, has a seizure, is experiencing trouble breathing, or cannot be awakened (loss of consciousness).

The management of overdose is defined as symptomatic and supportive treatment. The official label states that there is no known specific antidote to cetirizine, and the substance is not effectively removed by dialysis. Procedures like gastric lavage or the administration of activated charcoal may be considered in management following acute ingestion.

Therapeutic Uses of Cetriz

The primary therapeutic use of Cetriz (Cetirizine) is to provide sustained supportive relief from a broad range of symptoms related to heightened physiological activity caused by allergic reactions. The medication is commonly applied in addressing conditions characterized by episodic or fluctuating symptom patterns, including allergic rhinitis (seasonal and perennial), urticaria (hives), and allergic conjunctivitis.

Supportive Management of Allergic Discomfort

Cetriz is used for managing symptom clusters that may interfere with daily comfort, such as persistent sneezing, a runny nose (rhinorrhea), and challenging skin pruritus (itching). It is relevant for easing symptoms related to skin discomfort and ocular issues like red, tearing, and itchy eyes. This supportive relief may assist with improving day-to-day comfort during episodes of heightened symptoms.

“Applied in scenarios where additional management of discomfort is required, the medication helps address groups of symptoms that may appear suddenly or intensify over time.”

Quick Fact: Context for Allergic Pruritus Cetriz is commonly used for managing generalized intense itching (pruritus) and supportive relief for the visible manifestations associated with chronic urticaria (hives), contributing to easing the overall symptom load.

Regulatory References

  1. Cetirizine - StatPearls - NCBI Bookshelf - NIH

Eligibility and Restrictions for Use

Absolute Contraindications

Cetriz is strictly contraindicated and must not be used by specific patient groups, as defined in official regulatory labeling. This absolute prohibition applies to individuals with a known history of hypersensitivity to the active substance, Cetirizine Dihydrochloride, or to any related compounds, including hydroxyzine and other piperazine derivatives. Use is also prohibited for patients with severe renal impairment or end-stage kidney disease, typically defined as a Creatinine Clearance below 10 mL/min [Source 2.8].

Age and Conditional Eligibility Rules

Eligibility is established for adults and adolescents 12 years of age and older. For the pediatric population, eligibility is stratified by age: oral liquid formulations may be approved starting from 6 months of age for specific indications, while standard tablet formulations are generally restricted to children 6 years and older. Use is not established for infants under 6 months [Source 1.4, 2.2].

Conditional use applies to patients with mild-to-moderate renal impairment or predisposing factors for urinary retention; these patient groups require use under restricted conditions. Additionally, official documents advise caution when prescribing to pregnant or lactating women [Source 2.2, 4.4].

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Cetirizine Dihydrochloride is structured around specific pharmacokinetic and pharmacodynamic interaction patterns.

Pharmacodynamic and Pharmacokinetic Interactions

  • Central Nervous System (CNS) Depressants: Co-administration with substances such as alcohol, sedatives, or tranquilizers may result in an additive pharmacodynamic effect, causing additional reductions in alertness and increased impairment of performance.
  • Theophylline: Co-administration of Theophylline (at a daily dose of 400 mg) is associated with Altered Pharmacokinetic Clearance, specifically a 16% decrease in the clearance of cetirizine. The disposition of Theophylline itself remains unaffected.
  • Other Drug Studies: Pharmacokinetic interaction studies with medicines including Pseudoephedrine, Azithromycin, Erythromycin, and Ketoconazole demonstrated no clinically significant interactions on cetirizine exposure.

Product and Condition-Specific Considerations

  • Food and Absorption: The intake of food does not affect the overall amount of drug absorbed (extent of exposure); however, it results in a decrease in the rate of absorption, delaying the time required to reach peak concentration.
  • Chronic Hepatic Impairment: Patients with documented chronic liver disease exhibit altered pharmacokinetics for cetirizine, showing a 40% decrease in clearance and a 50% increase in half-life. This population-specific change in clearance is officially noted.

Mechanism of Action

Highly Selective Peripheral H1 Receptor Blockade

This domain covers the drug's primary action: binding as a competitive antagonist and inverse agonist to the peripheral Histamine H1 Receptor ( H1R). The high-affinity binding blocks the receptor, preventing endogenous histamine from activating the cellular cascade that initiates immediate physiological responses. This interruption in H1 signaling suppresses vasodilation and maintains capillary integrity, which prevents histamine-induced plasma exudation and capillary leakage.

Modulation of Cellular Inflammatory Pathways

Beyond simple receptor blockade, the mechanism extends to modulating the broader inflammatory response by suppressing the chemotaxis and activation of specific immune cells, such as eosinophils. By inhibiting the recruitment of these cells and reducing the release of certain secondary pro-inflammatory mediators, the drug modulates the progression of the late-phase allergic response. This sustained action reduces the prolonged physiological burden on tissues.

Constraint by Peripheral Selectivity

The molecule's low lipophilicity and zwitterionic structure act as a physical constraint, limiting its diffusion across the Blood-Brain Barrier (BBB). This design results in high peripheral selectivity, meaning the mechanism targets H1 receptors mainly outside the central nervous system (CNS). This constraint confines its action to peripheral systems, as it minimally engages the central histaminergic system responsible for regulating alertness.

Dosage and Administration Information

How to Use Cetriz: Official Administration Guidelines

The administration of Cetirizine Dihydrochloride, the active ingredient in Cetriz, is based on established administration protocols. The medicine is primarily taken by the Oral route, encompassing forms such as tablets, oral solutions, and syrups. An Intravenous (IV) solution is also an approved route for use in specific acute clinical scenarios.

Standardized Dosing and Frequency

The standard adult oral regimen involves taking 5 mg or 10 mg once every 24 hours, with the maximum recommended dose not exceeding 10 mg per day. The oral forms may be consumed with or without food, as meals do not alter the total amount of drug absorbed. If a once-daily dose is missed, it should be skipped, and the standard schedule should be resumed at the next scheduled time; taking two doses to compensate is not advised.

Population-Specific Use

Official instructions include specific modifications for certain populations. For older adults and patients with impaired renal function, a lower initial dose of 5 mg once daily or a reduced frequency (e.g., once every two days) is typically required, based on the degree of kidney function. For children aged 6 to 11 years, the official dose can be 5 mg twice daily or 10 mg once daily, with the liquid formulation generally being specified for precise dosing in younger age groups. These structured rules ensure the proper administration of the medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cetriz (Cetirizine Dihydrochloride)

This section summarizes the types of clinical research available for Cetriz (Cetirizine), detailing what the studies focused on and what remains uncertain, based on official regulatory and scientific sources. The findings describe group patterns observed in studies and provide context, but they are not personal predictions.

Evidence for Symptom Management in Seasonal Allergic Rhinitis (SAR)

Research on the use of Cetriz for seasonal allergic rhinitis is documented in a volume of short-term randomized controlled trials (RCTs). These studies were used in research exploring how symptoms change over time, comparing the effects of Cetriz against an inactive substance or sometimes against other medicines. Trials typically involve Adults, Adolescents, and Children (≥ 2 years old).

Researchers focused on measuring patient-reported outcomes describing perceived discomfort. These included scores for individual nasal and ocular symptoms, often combined into a Total Symptom Score (TSS). Studies also monitored changes in outcomes reflecting daily functioning by applying in studies examining patient-reported experiences related to functional scales.

Evidence for Managing Chronic and Perennial Allergies

Research examined its application in conditions characterized by fluctuating manifestations, such as perennial allergic rhinitis (PAR) and chronic urticaria (hives). For PAR, the research involved RCTs and longer observational studies, exploring outcomes capturing phases of heightened symptom activity. For chronic urticaria, studies focused on measurable changes in the visible hives, or wheals, and the severity of pruritus (itching).

Research Gaps and Areas of Uncertainty

Scientific reviews identify limitations, including that most high-quality evidence is derived from short-term trials (typically 1 to 4 weeks). Therefore, long-term effects are not fully established regarding the sustained symptom patterns of allergic conditions beyond the intermediate term. Additionally, subgroup findings are uncertain, as specific data for certain comorbidity groups remain insufficient. Comparative evidence against some other second-generation antihistamine agents is also lacking.

Frequently Asked Questions (FAQ)

Common questions about Cetriz (FAQ)

Q: How quickly does Cetriz start working after I take it?

A: According to official product information, the effects of cetirizine typically begin within 20 to 60 minutes after administration. The medicine reaches its maximum concentration in the blood within approximately one hour.

Q: Is it normal to feel a little tired the first few times using Cetriz?

A: Drowsiness, also known as somnolence, is a commonly reported side effect of this medicine. Regulatory information advises that this possibility exists and that caution should be taken when performing activities that require full mental alertness.

Q: What is Cetriz primarily used for?

A: Official information states that cetirizine is approved for the temporary relief of symptoms associated with seasonal and perennial allergic rhinitis (hay fever or indoor/outdoor allergies). It is also approved for treating chronic urticaria (long-term hives) and the associated itching.

Q: Are there any long-term side effects associated with taking Cetriz?

A: Most official evidence for cetirizine comes from short-term studies. While known side effects are documented from these trials and post-marketing reports, official guidance notes that the effects of using the medication for very extended periods have not been fully established in long-term trials.

Q: Does Cetriz interact with blood pressure medication?

A: Cetirizine used alone is not specifically reported in official documents to interact with most blood pressure medications. However, if using a combination product containing a decongestant (such as pseudoephedrine) along with cetirizine, patients should be aware that decongestants can potentially affect blood pressure.

Q: Can Cetriz be used for managing chronic hives?

A: Yes, chronic urticaria (hives) and the associated pruritus (itching) are approved indications for cetirizine. It is used to help relieve the symptoms of these long-term skin conditions.

Q: Does taking Cetriz affect driving or operating machinery?

A: Official warnings state that drowsiness is possible when using this product. Therefore, it is advised to be mindful of this potential effect before engaging in tasks that require full mental alertness, such as driving or operating machinery.

Q: Does Cetriz interact with certain herbal supplements?

A: Regulatory guidance indicates that if taking herbal supplements that also cause effects like sleepiness, dry mouth, or difficulty urinating, combining them with Cetriz may lead to an increased effect of those side effects.

Q: Is there a generic version of Cetriz available?

A: Yes, the active pharmaceutical ingredient is cetirizine hydrochloride, and generic versions of the medicine are widely available in the marketplace, as the original brand patent has expired.

Q: Is Cetriz sold over-the-counter or does it require a prescription?

A: In many regions, cetirizine is designated as a Human Over-The-Counter (OTC) Drug for allergy relief. It can often be purchased without a doctor’s prescription.

Q: Can Cetriz be taken on an empty stomach?

A: Official administration instructions confirm that the oral forms of the medicine may be consumed with or without food. While food may slightly delay the time it takes to reach maximum effect, it does not change the total amount of medicine absorbed.

Q: Is it normal to feel a bit dizzy after taking Cetriz?

A: Dizziness is listed in official documents as a possible, though less common, side effect of the medicine. As with other potential effects like drowsiness, caution should be used when performing tasks that require full mental alertness.

Q: What is the chemical name for the active ingredient in Cetriz?

A: The active pharmaceutical ingredient is Cetirizine Dihydrochloride. This is the standard, official name used in product labeling and regulatory documents.

Q: Is there a risk of withdrawal symptoms when stopping Cetriz?

A: Official warnings note that rare cases of severe pruritus (intense itching) have been reported upon stopping the medicine, especially after long-term use. This specific reaction is officially documented under discontinuation warnings.

Q: Are there different strengths of Cetriz tablets available?

A: Official product information confirms that cetirizine tablets are typically available in 5 mg and 10 mg strengths.

Q: What is the half-life of Cetriz in the body?

A: Pharmacokinetic data indicates that the elimination half-life of cetirizine in the body, which is the time it takes for half of the drug to be cleared, is approximately 8.3 hours in adults with normal kidney function.

Q: Can Cetriz help with post-nasal drip from allergies?

A: The medicine is indicated for the temporary relief of common upper respiratory allergy symptoms, including a runny nose and sneezing. These effects can help address the congestion and inflammation often associated with post-nasal drip.

Q: Does Cetriz interact with oral contraceptives (birth control pills)?

A: Official drug interaction studies do not typically list an interaction between cetirizine and oral contraceptives. However, the use of all medications and supplements should be reviewed by a qualified healthcare professional.

Q: What is the maximum duration someone can take Cetriz continuously?

A: Regulatory guidelines state that the duration of treatment is not fixed. The length of time the medicine is taken is based on the specific type, duration, and course of the allergic complaints.

How should Cetriz be stored and disposed of?

How to Store and Dispose of Cetriz (Cetirizine Dihydrochloride)

Official regulatory guidelines define precise storage and disposal protocols for cetirizine to maintain drug stability and public safety.

Storage Requirements

Cetriz must be stored at Controlled Room Temperature, typically 20^circ to 25 C (68^circ to 77 F), and protected from excessive heat (above 40 C) and freezing. The medication must be kept in its original closed container and protected from light and moisture. To prevent accidental ingestion, always store the product out of the sight and reach of children.

Disposal Instructions

Unused or expired Cetriz should not be flushed down the toilet or poured down a sink unless specifically instructed by the label. The preferred method for disposal is through an official drug take-back program. If a take-back program is unavailable, follow specific government-recommended household disposal steps, which generally involve mixing the medicine with an undesirable substance (e.g., dirt) and sealing it before placing it in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Cetriz found in:

A-Z Index: